UK clinical guideline for the prevention and treatment of osteoporosis

CL Gregson, DJ Armstrong, J Bowden, C Cooper… - Archives of …, 2022 - Springer
Abstract Summary The National Osteoporosis Guideline Group (NOGG) has revised the UK
guideline for the assessment and management of osteoporosis and the prevention of …

Congenital adrenal hyperplasia—current insights in pathophysiology, diagnostics, and management

HL Claahsen-van der Grinten, PW Speiser… - Endocrine …, 2022 - academic.oup.com
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders affecting
cortisol biosynthesis. Reduced activity of an enzyme required for cortisol production leads to …

[HTML][HTML] Sarilumab for relapse of polymyalgia rheumatica during glucocorticoid taper

RF Spiera, S Unizony, KJ Warrington… - … England Journal of …, 2023 - Mass Medical Soc
Background More than half of patients with polymyalgia rheumatica have a relapse during
tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 …

British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

CA Lamb, NA Kennedy, T Raine, PA Hendy, PJ Smith… - Gut, 2019 - gut.bmj.com
Ulcerative colitis and Crohn's disease are the principal forms of inflammatory bowel disease.
Both represent chronic inflammation of the gastrointestinal tract, which displays …

Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment

P Chotiyarnwong, EV McCloskey - Nature Reviews Endocrinology, 2020 - nature.com
Glucocorticoids are widely used to suppress inflammation or the immune system. High
doses and long-term use of glucocorticoids lead to an important and common iatrogenic …

The endothelium–bone axis in development, homeostasis and bone and joint disease

J Tuckermann, RH Adams - Nature Reviews Rheumatology, 2021 - nature.com
Blood vessels form a versatile transport network that is best known for its critical roles in
processes such as tissue oxygenation, metabolism and immune surveillance. The …

A comprehensive overview on osteoporosis and its risk factors

F Pouresmaeili, B Kamalidehghan… - … and clinical risk …, 2018 - Taylor & Francis
Osteoporosis is a bone disorder with remarkable changes in bone biologic material and
consequent bone structural distraction, affecting millions of people around the world from …

Managing osteoporosis in patients on long‐term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research

RA Adler, G El‐Hajj Fuleihan, DC Bauer… - Journal of Bone and …, 2016 - academic.oup.com
Bisphosphonates (BPs) are the most commonly used medications for osteoporosis. This
ASBMR report provides guidance on BP therapy duration with a risk‐benefit perspective …

[HTML][HTML] Major osteoporotic fragility fractures: Risk factor updates and societal impact

P Pisani, MD Renna, F Conversano… - World journal of …, 2016 - ncbi.nlm.nih.gov
Osteoporosis is a silent disease without any evidence of disease until a fracture occurs.
Approximately 200 million people in the world are affected by osteoporosis and 8.9 million …

Infection risk and safety of corticosteroid use

J Youssef, SA Novosad… - Rheumatic Disease …, 2016 - rheumatic.theclinics.com
Because of their potent anti-inflammatory properties, corticosteroids have been used for
decades to treat many diseases, including rheumatic diseases. They are frequently used in …